MT Newswires
European Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading
📊
AI Sentiment
Positive
7/10
- Home
- CLLS
CLLS
Cellectis S.A.
as of 11-28-2025 12:17pm EST
$4.98
$0.06
-1.19%
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Chart Type:
Time Range:
| Founded: | 1999 | Country: | France |
| Employees: | N/A | City: | N/A |
| Market Cap: | 299.0M | IPO Year: | 2007 |
| Target Price: | $8.00 | AVG Volume (30 days): | 124.5K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.35 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.10 - $5.48 | Next Earning Date: | 11-07-2025 |
| Revenue: | $82,551,000 | Revenue Growth: | 129.04% |
| Revenue Growth (this year): | -12.05% | Revenue Growth (next year): | 58.00% |
AI-Powered CLLS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 79.59%
79.59%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Cellectis S.A. News
CLLS Breaking Stock News: Dive into CLLS Ticker-Specific Updates for Smart Investing
MT Newswires
European Equities Traded in the US as American Depositary Receipts Turn Sharply Higher in Tuesday Trading
📊
AI Sentiment
Positive
7/10
Compare CLLS vs Leading Stocks
See how CLLS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CLLS Cellectis S.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.